OQROGet OQRO Pro
Insider trade

Protagonist Therapeutics, Inc. (PTGX)CEO sold ~$205K

PATEL DINESH V PH D, CEO at Protagonist Therapeutics, Inc., sold ~$205K of Protagonist Therapeutics, Inc. shares.

~$205K
Approx. value · 5,359 sh @ $38.18
540K
Holds after · shares reported
Traded
Feb 19, 2025
Filed
Feb 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 19, 2025 · this disclosureInsiderCEO sold ~$205K of PTGX shares in the open market

What came next

  1. Mar 12, 2025InsiderCFO sold ~$1.46M of PTGX shares in the open market
  2. Mar 13, 2025InsiderOfficer sold ~$1.7M of PTGX shares in the open market
  3. Mar 17, 2025InsiderDirector sold ~$217K of PTGX shares in the open market
  4. Apr 22, 2025InsiderCFO sold ~$81K of PTGX shares in the open market
  5. Jun 9, 2025InsiderOfficer sold ~$555K of PTGX shares in the open market
  6. Jun 10, 2025InsiderOfficer sold ~$570K of PTGX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Protagonist Therapeutics, Inc.

For Protagonist Therapeutics, Inc., OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PTGX page.

Other recent filings by PATEL DINESH V PH D, President and CEO

The full history of PATEL DINESH V PH D, President and CEO is on the profile page.

How this filing works

Other disclosures at Protagonist Therapeutics, Inc.

Everything OQRO holds on this company is on its PTGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data